Atherosclerosis
Volume 211, Issue 1 , Pages 96-102 , July 2010

Conjugated linoleic acid suppresses the migratory and inflammatory phenotype of the monocyte/macrophage cell

  • Sarah McClelland

      Affiliations

    • School of Biomedical and Biomolecular Science, UCD Conway Institute, University College Dublin, Ireland
  • ,
  • Clare Cox

      Affiliations

    • School of Biomedical and Biomolecular Science, UCD Conway Institute, University College Dublin, Ireland
  • ,
  • Roisin O’Connor

      Affiliations

    • Wolfson Institute for Biomedical Research, University College London, UK
  • ,
  • Monica de Gaetano

      Affiliations

    • School of Biomedical and Biomolecular Science, UCD Conway Institute, University College Dublin, Ireland
  • ,
  • Cathal McCarthy

      Affiliations

    • School of Biomedical and Biomolecular Science, UCD Conway Institute, University College Dublin, Ireland
  • ,
  • Lorna Cryan

      Affiliations

    • Vascular Biology Programme, Boston Children's Hospital, Boston, MA, USA
  • ,
  • Des Fitzgerald

      Affiliations

    • School of Biomedical and Biomolecular Science, UCD Conway Institute, University College Dublin, Ireland
  • ,
  • Orina Belton

      Affiliations

    • School of Biomedical and Biomolecular Science, UCD Conway Institute, University College Dublin, Ireland
    • Corresponding Author InformationCorresponding author. Tel.: +353 1 7166748; fax: +353 1 7166701.

Received 19 November 2009 ,Revised 18 January 2010 ,Accepted 2 February 2010.

References 

  1. Arbonés-Mainar JM, Navarro MA, Guzmán MA, et al. Selective effect of conjugated linoleic acid isomers on atherosclerotic lesion development in apolipoprotein E knockout mice. Atherosclerosis. 2006;189:318–327
  2. Navarro V, Zabala A, Macarulla MT, et al. Effects of conjugated linoleic acid on body fat accumulation and serum lipids in hamsters fed an atherogenic diet. J Physiol Biochem. 2003;59:193–199
  3. Kritchevsky D, Tepper SA, Wright S, Tso P, Czarnecki SK. Influence of conjugated linoleic acid on establishment and progression of atherosclerosis in rabbits. J Am Coll Nutr. 2000;19:472–477
  4. Toomey S, Harhen B, Roche HM, Fitzgerald D, Belton O. Profound resolution of early atherosclerosis with conjugated linoleic acid. Atherosclerosis. 2006;187:40–49
  5. Massberg S, Brand K, Grüner S, et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med. 2002;196:887–896
  6. Shah PK, Falk E, Badimon JJ, et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation. 1995;92:1565–1569
  7. Li AC, Brown KK, Silvestre MJ, Willson TM, Palinski W, Glass CK. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice. J Clin Invest. 2000;106:523–531
  8. Chen Z, Ishibashi S, Perrey S, et al. Troglitazone inhibits atherosclerosis in apolipoprotein E-knockout mice: pleiotropic effects on CD36 expression and HDL. Arterioscler Thromb Vasc Biol. 2001;21:372–377
  9. Pasceri V, Wu HD, Willerson JT, Yeh ET. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activaed receptor-gamma activators. Circulation. 2000;101(3):235–238
  10. Bozzo F, Bocca C, Colombatto S, Miglietta A. Antiproliferative effect of conjugated linoleic acid in caco-2 cells: involvement of PPARgamma and APC/beta-catenin pathways. Chem Biol Interact. 2007;169:110–121
  11. Bergamo P, Luongo D, Maurano F, Mazzarella G, Stefanile R, Rossi M. Conjugated linoleic acid enhances glutathione synthesis and attenuates pathological signs in MRL/MpJ-Fas(lpr) mice. J Lipid Res. 2006;47:2382–2391
  12. Belton O, Byrne D, Kearney D, Leahy A, Fitzgerald DJ. Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. Circulation. 2000;102:840–845
  13. Iwakiri Y, Sampson DA, Allen KG. Suppression of cyclooxygenase-2 and inducible nitric oxide synthase expression by conjugated linoleic acid in murine macrophages. Prostaglandins Leukot Essent Fatty Acids. 2002;67:435–443
  14. Ringseis R, Schulz N, Saal D, Eder K. Troglitazone but not conjugated linoleic acid reduces gene expression and activity of matrix-metalloproteinases-2 and -9 in PMA-differentiated THP-1 macrophages. J Nutr Biochem. 2008;19:594–603
  15. Chan ES, Zhang H, Fernandez P, et al. Effect of cyclooxygenase inhibition on cholesterol efflux proteins and atheromatous foam cell transformation in THP-1 human macrophages: a possible mechanism for increased cardiovascular risk. Arthritis Res Ther. 2007;9:R4
  16. Coppinger JA, Cagney G, Toomey S, et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood. 2004;103:2096–2104
  17. Soel SM, Choi OS, Bang MH, Yoon Park JH, Kim WK. Influence of conjugated linoleic acid isomers on the metastasis of colon cancer cells in vitro and in vivo. J Nutr Biochem. 2007;18:650–657
  18. Gosling J, Slaymaker S, Gu L, et al. MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest. 1999;103:773–778
  19. Massberg S, Schürzinger K, Lorenz M, et al. Platelet adhesion via glycoprotein IIb integrin is critical for atheroprogression and focal cerebral ischemia: an in vivo study in mice lacking glycoprotein IIb. Circulation. 2005;112:1180–1188
  20. McClelland S, Gawaz M, Kennerknecht E, et al. Contribution of cyclooxygenase-1 to thromboxane formation, platelet-vessel wall interactions and atherosclerosis in the ApoE null mouse. Atherosclerosis. 2009;202:84–91
  21. Huo Y, Schober A, Forlow SB, et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med. 2003;9:61–67
  22. Coppinger JA, O’Connor R, Wynne K, et al. Moderation of the platelet releasate response by aspirin. Blood. 2007;109:4786–4792
  23. Kintscher U, Goetze S, Wakino S, et al. Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes. Eur J Pharmacol. 2000;401:259–270
  24. Babaev VR, Yancey PG, Ryzhov SV, et al. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol. 2005;25:1647–1653
  25. Belton OA, Duffy A, Toomey S, Fitzgerald DJ. Cyclooxygenase isoforms and platelet vessel wall interactions in the apolipoprotein E knockout mouse model of atherosclerosis. Circulation. 2003;108:3017–3023
  26. Ringseis R, Gahler S, Herter C, Eder K. Conjugated linoleic acids exert similar actions on prostanoid release from aortic and coronary artery smooth muscle cells. Int J Vitam Nutr Res. 2006;76:281–289
  27. Stachowska E, Dziedziejko V, Safranow K, et al. Inhibition of phospholipaseA(2) activity by conjugated linoleic acids in human macrophages. Eur J Nutr. 2007;46:28–33
  28. Panzer U, Uguccioni M. Prostaglandin E2 modulates the functional responsiveness of human monocytes to chemokines. Eur J Immunol. 2004;34:3682–3689
  29. Tajima T, Murata T, Aritake K, et al. Lipopolysaccharide induces macrophage migration via prostaglandin D(2) and prostaglandin E(2). J Pharmacol Exp Ther. 2008;326:493–501
  30. Waldo SW, Li Y, Buono C, et al. Hetergeneity of human macrophages in culture and in atherosclerotic plaques. Am J Pathol. 2008;172(4):1112–1126

PII: S0021-9150(10)00101-2

doi: 10.1016/j.atherosclerosis.2010.02.003

Atherosclerosis
Volume 211, Issue 1 , Pages 96-102 , July 2010